In addition to PPAR-α, other PPARs like PPAR-γ have emerged as an important player in treatment of type-2-diabetes (T2DB) and PPAR-γ ligands, thiazolidinediones are used clinically for the treatment of T2DB [75]. Here, PPARG is linked to type 2 diabetes mellitus.